Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0625-5
- By:
- Publication type:
- Article
Works matching IS 15233774 AND DT 2016 AND VI 18 AND IP 12
Results: 7
1
2
Imaging in Juvenile Spondyloarthritis.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0624-6
- By:
- Publication type:
- Article
3
Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0620-x
- By:
- Publication type:
- Article
4
Monogenic Lupus.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0621-9
- By:
- Publication type:
- Article
5
Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0622-8
- By:
- Publication type:
- Article
6
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0623-7
- By:
- Publication type:
- Article
7
Predictors of Poor Outcome in ANCA-Associated Vasculitis (AAV).
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11926-016-0619-3
- By:
- Publication type:
- Article